GPX4 Flag&His Tag Recombinant Protein: A Key Research Tool for the Core Regulator of Ferroptosis

I. Overview: The Central Role of GPX4 in Ferroptosis and Research Challenges

Glutathione peroxidase 4 (GPX4) is a core inhibitory protein in the ferroptosis regulatory network. It catalyzes the glutathione (GSH)-dependent reduction of lipid hydroperoxides (LOOH), thereby blocking the chain reaction of lipid peroxidation and maintaining cell membrane integrity. Loss of GPX4 function is a sufficient condition to induce ferroptosis. Studying its enzymatic activity regulation mechanisms and developing specific inhibitors or activators is crucial for understanding pathological processes such as cancer, neurodegenerative diseases, and ischemia-reperfusion injury. However, GPX4 protein exhibits strong hydrophobicity and sensitivity to redox environments, posing challenges for in vitro studies. The GPX4 Flag&His Tag recombinant protein, as a standardized purification and detection tool, provides an effective solution to overcome these technical difficulties.

II. Molecular Construction and Expression/Purification Strategies

Typical commercial or self-constructed GPX4 recombinant proteins employ a dual-affinity tag design to achieve efficient purification and flexible detection.

Core Protein Forms:

Usually the full-length sequence of human GPX4, with a molecular weight of approximately 22 kDa (excluding the tag portion). Some products also provide major isoforms (e.g., mitochondrial form).

Tag Design:

His tag (6xHis): Provides efficient, high-capacity binding to nickel (Ni²⁺) or cobalt (Co²⁺) chelating resins, suitable for initial capture. Purification is typically performed under non-denaturing conditions with reducing agents (e.g., DTT or TCEP) to maintain the enzyme's essential reduced state.

Flag tag: Located at the N- or C-terminus of the protein, providing a highly specific recognition site for subsequent immunodetection, co-immunoprecipitation (Co-IP), or affinity purification.

Expression System:

Primarily produced in E. coli expression systems for high yield and low cost. The recombinant protein is obtained through denaturation and renaturation steps or expressed under soluble conditions. To achieve correctly folded and active enzyme, the purification process must strictly maintain a reducing environment, and may require in vitro supplementation of the critical selenocysteine (Sec) post-purification to restore full enzymatic activity (some products substitute Sec with cysteine).

III. Core Application Scenarios

Ferroptosis Mechanism Research:

In vitro activity validation: Using purified GPX4 Flag&His protein, along with GSH and specific substrates (e.g., hydrogen peroxide or phospholipid hydroperoxide analogs), enzyme kinetic parameters (Km, Vmax) can be directly measured via spectrophotometry or fluorescence assays to evaluate the effects of different redox conditions or mutations on activity.

Interaction protein screening: The Flag tag enables co-immunoprecipitation, using GPX4 as "bait" to capture potential regulatory proteins or complexes from cell lysates, thereby elucidating its upstream regulatory network.

Drug Discovery and Screening:

Direct inhibitor screening: The purified GPX4 protein serves as a target for high-throughput in vitro enzyme inhibition assays using microplates, screening small molecule libraries for compounds that directly inhibit its activity (e.g., covalent inhibitors like ML162 or RSL3), and calculating IC50 values.

Inhibitor mechanism studies: Competitive binding assays, mass spectrometry, or surface plasmon resonance (SPR) can be used to study the binding sites, stoichiometry (using His tag for protein immobilization), and covalent modification sites of candidate drugs with GPX4.

Structural Biology Research:

High-purity, homogeneous dual-tagged GPX4 protein is essential for X-ray crystallography or cryo-EM analysis to resolve its three-dimensional structure in complex with substrates or inhibitors, guiding structure-based drug design.

IV. Advantages of Dual-Tag-Based Experimental Protocols

Purification process optimization: Tandem or stepwise use of immobilized metal affinity chromatography (IMAC) and anti-Flag antibody affinity chromatography yields extremely high-purity protein, effectively removing host proteins and endotoxins to meet the requirements of high-sensitivity biochemical and cellular experiments.

Flexible detection and tracing: Both tags have commercially available, highly specific antibodies. Anti-His antibodies are commonly used for Western Blot to quickly detect expression and purification, while anti-Flag antibodies, due to their exceptional specificity, are more suitable for stringent experiments like immunoprecipitation and immunofluorescence.

Convenient immobilization: The His tag facilitates directional immobilization of the protein on biosensor chips (for SPR/BLI kinetic analysis) or microplates for molecular interaction studies.

V. Research Considerations and Technical Points

Activity maintenance: GPX4 activity strictly depends on its active-site selenocysteine and reduced glutathione. All operating buffers must contain sufficient reducing agents (1-5 mM DTT or TCEP) and avoid exposure to oxidizing environments.

Storage conditions: Purified protein should be aliquoted and stored at -80°C in buffers containing glycerol and reducing agents, avoiding repeated freeze-thaw cycles.

Control design: Using catalytically inactive GPX4 mutants (e.g., Sec→Cys or Ser) as negative controls is critical for distinguishing the specific effects of drugs or conditions on enzyme activity.

VI. Summary

The GPX4 Flag&His Tag recombinant protein, through its stable and efficient dual-tag system, successfully transforms a key redox enzyme—prone to degradation in vivo and challenging to study—into a research object that can be precisely quantified and manipulated in vitro. It has become a core reagent for in-depth exploration of the molecular mechanisms of ferroptosis and directly advances the development of small-molecule inhibitors (for inducing ferroptosis in cancer cells) or stabilizers (for neuroprotection) targeting GPX4. The application of this tool significantly accelerates the translation of basic biological discoveries into potential therapeutic strategies.